Daniel Boisvert earned his Bachelor of Science degree in Chemistry from the University of Massachusetts at Amherst. He then began his 15-year career at Pfizer as an analytical chemist developing novel analytical methods for excipients and raw materials. Dan then took on roles of increasing responsibility including managing stability studies, co-chair of the Pfizer disulfide and trisulfide bond team, as well as the analytical lead for protein therapeutic programs. He is currently a member of the Pfizer Dosage and Administration Instructions (DAI) group, representing analytical method development. In his spare time, Dan enjoys reading, hiking, and fishing with his two young children.